Address: 50 Soldiers Field Place, Boston, MA 02135 (America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Chimeric antigen receptor T cell (CAR-T) refers to the transfer of genetic material with specific antigen recognition domain and T cell activation signal into T cells through gene modification technology, so that T cells can be transformed into T cells. It is activated by directly binding to specific antigens on the surface of tumor cells, directly killing tumor cells by releasing perforin, granzyme B, etc., and at the same time, it also recruits human endogenous immune cells to kill tumor cells by releasing cytokines, so as to achieve therapeutic effect. It can also form immune memory T cells to obtain a specific long-acting mechanism against liver tumors.